Fatigue News and Research

RSS

Analysis supports phase 3 trials of Johnson & Johnson's COVID-19 vaccine

Researchers in the Netherlands, the United States, and Belgium have presented early-stage clinical trial results demonstrating the safety and efficacy of Johnson & Johnson's vaccine candidate for coronavirus disease 2019 (COVID-19).

17 Jan 2021

New drug reduces tumor volume and pain in patients with neurofibromatosis type 1

Based on preclinical studies of an investigational drug to treat peripheral nerve tumors, researchers at Children's Hospital of Philadelphia (CHOP) as part of the Neurofibromatosis Clinical Trials Consortium have shown that the drug, cabozantinib, reduces tumor volume and pain in patients with the genetic disorder neurofibromatosis type 1 (NF1).

15 Jan 2021

COVID-19 survivors can show persistent symptoms six months after recovery, study finds

A team of researchers conduct a large study exploring the persistence of COVID-19 symptoms in recovered patients.

13 Jan 2021

Medical institutions should support health care workers with COVID-19 infection, say experts

By mid-November, the Centers for Disease Control and Prevention had reported that 218,439 health care workers in the U.S. had been infected with COVID-19 -- a likely underestimate due to incomplete data from states.

13 Jan 2021

Clinicians at leading cardiac center report burnout and high levels of distress

More than half the clinicians surveyed at the Peter Munk Cardiac Centre reported burnout and high levels of distress according to a series of studies published today in the Canadian Medical Association Journal Open.

12 Jan 2021

Study reveals six-month consequences of COVID-19 in patients discharged from hospital

More than three quarters of COVID-19 patients have at least one ongoing symptom six months after initially becoming unwell, according to research published in The Lancet.

8 Jan 2021

Study: Initial COVID-19 severity is not linked to later poor respiratory problems

A new study published online in the Annals of the American Thoracic Society examines the recovery of lung function and overall wellness in individuals who had varying degrees of COVID-19 severity.

8 Jan 2021

Study explores women's interest in long-acting injectable antiretroviral therapy

A study led by Columbia University Mailman School of Public Health researchers examines attitudes toward long-acting injectable (LAI) HIV therapies, among women with a history of injection--including medical purposes and substance use. The findings appear in the journal AIDS Patient Care and STDs.

7 Jan 2021

Sleep is more than rest for improving performance of the brain

Sleep is ubiquitous in animals and humans and vital for healthy functioning. Thus, sleep after training improves performance on various tasks in comparison to equal periods of active wakefulness.

7 Jan 2021

Patients with heart failure should take more precautions against COVID-19

Patients with acute heart failure nearly double their risk of dying if they get COVID-19, according to research published today in ESC Heart Failure, a journal of the European Society of Cardiology (ESC).

7 Jan 2021

Smokers at increased risk of developing symptomatic COVID-19

Smoking is associated with an increased risk of COVID-19 symptoms and smokers are more likely to attend hospital than non-smokers, a study has found.

6 Jan 2021

One-third of COVID-19 survivors manifest neurological problems

In a longitudinal study recently published on the preprint server medRxiv*, Andrea Pilotto et al. find that one-third of COVID-19 infection survivors have long-term neurological manifestations after hospitalization.

5 Jan 2021

NCCN publishes new informational resources on health and wellness for cancer survivors

Today, the National Comprehensive Cancer Network announced the publication of new, free informational resources on health and wellness for cancer survivors.

5 Jan 2021

Could asymptomatic SARS-CoV-2 screening in dental practices help prevent silent transmission?

Researchers conducted a mass, asymptomatic screening of patients in dental surgeries across Scotland to assess illustrate its potential utility in curbing silent transmission.

5 Jan 2021

Covid ‘decimated our staff’ as the pandemic ravages health workers of color in US

Last spring, New Jersey emergency room nurse Maritza Beniquez saw "wave after wave" of sick patients, each wearing a look of fear that grew increasingly familiar as the weeks wore on.

5 Jan 2021

Inflammation marker linked to increased fatigue in prostate cancer patients treated with ADT

Prostate cancer is one of the most common cancers among men in the U.S. For many patients, hormone therapy is a treatment option.

4 Jan 2021

Study shows mRNA-1273 vaccine can prevent symptomatic COVID-19 infection

A peer-reviewed paper published in The New England Journal of Medicine provides data from the much-anticipated COVE study, which evaluated mRNA-1273, a vaccine candidate against COVID-19 manufactured by Moderna, Inc.

3 Jan 2021

Brain damage is not caused by direct COVID-19 attack, indicates study

n an in-depth study of how COVID-19 affects a patient's brain, National Institutes of Health researchers consistently spotted hallmarks of damage caused by thinning and leaky brain blood vessels in tissue samples from patients who died shortly after contracting the disease.

3 Jan 2021

Phase 3 results show investigational vaccine is effective in preventing severe COVID-19

The investigational vaccine known as mRNA-1273 was 94.1% efficacious in preventing symptomatic coronavirus disease 2019 (COVID-19), according to preliminary results from a Phase 3 clinical trial reported in the New England Journal of Medicine.

3 Jan 2021

Immunologic modeling of COVID-19 severity and chronicity

In a new study by researchers at Universidad de Costa Rica and other institutions, a bioinformatics approach is used to determine whether Chronic COVID-19 (CC) might have a distinct immunologic signature compared to the mild to moderate (MM) or the severe/critical COVID-19.

24 Dec 2020

Fatigue News and Research

Analysis supports phase 3 trials of Johnson & Johnson's COVID-19 vaccine

New drug reduces tumor volume and pain in patients with neurofibromatosis type 1

COVID-19 survivors can show persistent symptoms six months after recovery, study finds

Medical institutions should support health care workers with COVID-19 infection, say experts

Clinicians at leading cardiac center report burnout and high levels of distress

Study reveals six-month consequences of COVID-19 in patients discharged from hospital

Study: Initial COVID-19 severity is not linked to later poor respiratory problems

Study explores women's interest in long-acting injectable antiretroviral therapy

Sleep is more than rest for improving performance of the brain

Patients with heart failure should take more precautions against COVID-19

Smokers at increased risk of developing symptomatic COVID-19

One-third of COVID-19 survivors manifest neurological problems

NCCN publishes new informational resources on health and wellness for cancer survivors

Could asymptomatic SARS-CoV-2 screening in dental practices help prevent silent transmission?

Covid ‘decimated our staff’ as the pandemic ravages health workers of color in US

Inflammation marker linked to increased fatigue in prostate cancer patients treated with ADT

Study shows mRNA-1273 vaccine can prevent symptomatic COVID-19 infection

Brain damage is not caused by direct COVID-19 attack, indicates study

Phase 3 results show investigational vaccine is effective in preventing severe COVID-19

Immunologic modeling of COVID-19 severity and chronicity

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News